Home/Filings/4/0001310204-25-000017
4//SEC Filing

Dickinson Andrew D 4

Accession 0001310204-25-000017

CIK 0000882095other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 7:00 PM ET

Size

4.8 KB

Accession

0001310204-25-000017

Insider Transaction Report

Form 4
Period: 2025-11-17
Dickinson Andrew D
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-11-17$125.23/sh2,500$313,075154,555 total
Footnotes (1)
  • [F1]The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.

Issuer

GILEAD SCIENCES, INC.

CIK 0000882095

Entity typeother

Related Parties

1
  • filerCIK 0001310204

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 7:00 PM ET
Size
4.8 KB